Related Experiment Video
Updated: Jan 11, 2026

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
Published on: January 23, 2019
Endothelial Heterogeneity in Pulmonary Hypertension
Hanqiu Zhao1, Murali M Chakinala1, Michael B Fallon2
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine in St. Louis, MO (H.Z., M.M.C., S.M.L., J.S.L., Z.D.).
Pulmonary hypertension involves endothelial cell (EC) dysfunction, with distinct EC subsets driving disease complexity. Understanding this heterogeneity is key to developing new therapies for pulmonary hypertension.
Area of Science:
- Pulmonary vascular biology
- Endothelial cell biology
- Cardiovascular research
Background:
- The lung endothelium is vital for lung homeostasis and gas exchange.
- Endothelial cells (ECs) exhibit significant heterogeneity, influencing lung function.
- Pulmonary hypertension (PH) is characterized by EC dysfunction and vascular remodeling.
Purpose of the Study:
- To review recent insights into endothelial cell dysfunction in PH.
- To focus on the role of specialized EC subsets in PH pathogenesis.
- To explore novel therapeutic strategies targeting EC dysfunction in PH.
Main Methods:
- Review of current literature on EC heterogeneity and PH.
- Integration of single-cell RNA sequencing data.
- Analysis of molecular signatures and functional responses of EC subsets.
Main Results:
- Distinct pulmonary endothelial subpopulations display unique molecular profiles in PH.
- Endothelial heterogeneity contributes significantly to the complexity of PH.
- Specific EC subsets play critical roles in vascular remodeling associated with PH.
Conclusions:
- Endothelial cell heterogeneity is central to the pathogenesis of pulmonary hypertension.
- Targeting specialized EC subsets offers potential therapeutic avenues for PH.
- Advanced technologies are crucial for understanding EC roles in PH and developing innovations.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Regulation of Angiogenesis and Blood Supply
Overview of the Vascular System
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

